Description du projet
Renforcer la lutte contre les maladies infectieuses
Malgré les progrès réalisés dans le contrôle et la prévention des maladies, les maladies infectieuses (MI) restent l’une des menaces les plus complexes à traiter pour la santé et les économies mondiales. Réduire l’impact de leurs formes émergentes et la résistance aux antimicrobiens nécessite des efforts internationaux, durables et à long terme. Les consortia européens COMBACTE et PREPARE ont l’ambition commune de mettre en place une infrastructure paneuropéenne coordonnée et permanente pour la recherche clinique sur les MI (ECRAID). L’objectif d’ECRAID sera de réduire l’impact des MI sur la santé des personnes et de la population en générant des données précises afin d’améliorer le diagnostic, la prévention et le traitement des MI, et de mieux répondre aux menaces qu’elles représentent. Le projet ECRAID-Plan, financé par l’UE, soutiendra cet effort conjoint en développant le plan d’affaires détaillé pour ECRAID.
Objectif
Infectious diseases (ID) pose a continuous and serious threat to global health and economies. Reducing the impact of emerging infectious diseases (EID) and antimicrobial resistance (AMR) requires long-term, sustainable, international efforts. The European consortia COMBACTE and PREPARE have the joint ambition to establish a coordinated, permanent, pan-European infrastructure for clinical research on ID (ECRAID). The mission of ECRAID is to reduce the impact of ID on individual and population health by generating rigorous evidence to improve the diagnosis, prevention and treatment of IDs, and to better respond to ID threats. In ECRAID-Plan the coordinators and co-coordinators of PREPARE and COMBACTE, together with the (co-)coordinators of 12 other highly complementary networks and infrastructures, will develop a detailed Business Plan for ECRAID, which will serve: (i) as the guiding document in the implementation of ECRAID, (ii) to inform external stakeholders (network partners, industry, funders, policy makers, regulators, users) about ECRAID and (iii) to get commitment for sufficient start-up funding to commence operations in ECRAID, allowing for a smooth transition of activities from the current funding periods of PREPARE and COMBACTE. ECRAID-Plan will be completed within 24 months, involving extensive consultation of a multisectoral stakeholder platform. ECRAID-Plan will focus on the development of the key components of the business plan, including (i) an internal analysis of strengths and weaknesses, (ii) an external analysis of relevant stakeholders and their needs, developments in the scientific, policy and other domains and opportunities and threats, (iii) the service offering and business model, (iv) operational processes and policies, (v) governance structure and (vi) an investment plan and operational budget. Cross-cutting themes include reconciliation of AMR and EID research, data sharing and interoperabilty of networks.
Champ scientifique
Programme(s)
Régime de financement
CSA - Coordination and support actionCoordinateur
3584 CX Utrecht
Pays-Bas